Purpose: to provide clinical trials sponsor and regulatory management support services to the NCI, the center for cancer research (CCR), and CCR investigators.

Active Definitive Contract Awarded Last action

Contract number
75N91021C00013
Awardee
Awarding agency
Obligated
$71,253,101

Award facts

Contract value 62% obligated
  • $71,253,101.00 Current, with exercised options
  • $115,518,487.00 Potential, with all options
Completion date 54% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Westlake, MD 20817, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00011 · EO 14398 clinical trials sponsor and regulatory management support services to the NCI, the center for cancer research (CCR), and CCR investigators. $0
Exercise an Option P00010 · Clinical trials sponsor and regulatory management support services to the NCI, the center for cancer research (CCR), and CCR investigators. $9,874,915
Other Administrative Action P00009 $0
Exercise an Option P00008 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI clinical trials sponsor and regulatory… $9,551,909
Other Administrative Action P00007 $0
Exercise an Option P00006 $12,310,730
Exercise an Option P00005 · Clinical trials sponsor and regulatory management support services to the NCI, the center for cancer research (CCR), and CCR investigators. $13,590,124
Exercise an Option P00004 $13,164,829
Change Order P00003 $0
Other Administrative Action P00002 $0
Funding Only Action P00001 $9,570,446
Original award $3,190,149
Show all 12

About this award

The National Cancer Institute awarded a $115.5 million definitive contract to Technical Resources International, Inc., a minority-owned, woman-owned, Hispanic American-owned small business, for clinical trials sponsor and regulatory management support services on July 1, 2021, under a total small business set-aside.

The contract supports the NCI's Center for Cancer Research (CCR) and its investigators with compliance oversight, regulatory affairs, safety monitoring, clinical site assessment and interim monitoring, trial master file support, quality management, medical writing, and computerized tracking and reporting for multi-center clinical trials conducted at non-CCR sites. Place of performance is Westlake, MD. The contract carries a one-year base period plus nine one-year options, with ultimate completion on June 30, 2031. NAICS code is 541715 (research and development in the physical, engineering and life sciences).

Through FY2025, the contract invoiced $48.7 million across 224.4 FTEs and 366,312 contractor hours at a derived government-paid rate of $101.59 per hour, with no subcontractor engagement reported. FY2025 labor footprint stands at 48.3 FTEs. Invoicing ramped sharply from $537 thousand in FY2021 (contract startup) to peak invoicing of $13.5 million in FY2023, then stabilized at $11.2–12.8 million annually in FY2024–FY2025, suggesting normalized program execution post-ramp.

Quick answers

Who was awarded contract 75N91021C00013?

75N91021C00013 was awarded to Technical Resources International, Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2021.

How much is contract 75N91021C00013 worth?

The government has obligated $71,253,101 on 75N91021C00013. Its potential value, with all options, is $115,518,487.

Was contract 75N91021C00013 competed?

The extent of competition for 75N91021C00013 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award